Faeth Therapeutics, Inc. (FTH) Financials

FTH Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 189.3 million 16.3 million
March 31, 2026 205.4 million 14.2 million
Dec. 31, 2025 22.9 million 4.3 million
Sept. 30, 2025 27.6 million 4.6 million

FTH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -15.7 million 4.5 million
March 31, 2026 -10.7 million 12.9 million
Dec. 31, 2025 -3.9 million 295000
Sept. 30, 2025 -3.6 million 254000

FTH Net Income

No data available :(

FTH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 186.4 million - 592000
March 31, 2026 202.8 million - 1.0 million
Dec. 31, 2025 21.2 million 59000 1.5 million
Sept. 30, 2025 25.0 million - 2.0 million

FTH Shares Outstanding

No data available :(

FTH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 6000 9.2 million 9.2 million -
March 31, 2026 6000 18.0 million 19.7 million -
Dec. 31, 2025 - 2.2 million 2.8 million -
Sept. 30, 2025 - 2.5 million 2.3 million -

FTH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 133.0 million
Dec. 31, 2025 - -
Sept. 30, 2025 -4.9 million -4.9 million

FTH

Price: $33

52 week price:
7.20
37.90

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 34.2 million

Links: